(RDC) Redcare Pharmacy - Ratings and Ratios
Exchange: XETRA • Country: Netherlands • Currency: EUR • Type: Common Stock • ISIN: NL0012044747
RDC: Prescription, Over-The-Counter, Beauty, Personal, Food
Redcare Pharmacy NV is a leading European online pharmacy operator, serving customers in the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France. The company offers a wide range of products, including prescription and non-prescription pharmaceuticals, beauty and personal care items, and food supplements. Redcare Pharmacy NV, formerly known as Shop Apotheke Europe N.V., rebranded in June 2023 to reflect its expanded focus on healthcare and customer-centric services. Founded in 2001, the company is headquartered in Sevenum, the Netherlands, and has established itself as a key player in the European e-pharmacy market. Web URL: https://www.redcare-pharmacy.com
As of the latest data, Redcare Pharmacy NV (XETRA:RDC) is listed on the XETRA exchange as a common stock under the ticker symbol RDC. The company operates in the Drug Retail sub-industry and is categorized under the Netherlands as its country of origin. With a strong e-commerce platform, Redcare Pharmacy NV has been able to capitalize on the growing demand for online healthcare services in Europe.
3-Month Forecast: Based on the provided data, Redcare Pharmacy NV (XETRA:RDC) is expected to experience moderate price fluctuations. The stock is currently trading above its 20-day and 50-day moving averages but below the 200-day moving average, indicating a potential sideways trend. The Average True Range (ATR) of 6.94 suggests moderate volatility. Fundamentally, the high forward P/E ratio of 625.00 and negative Return on Equity (RoE) of -9.39% may signal investor caution. However, the Price-to-Sales (P/S) ratio of 1.07 indicates reasonable valuation relative to revenue. Overall, the stock may face headwinds due to high valuations and profitability challenges, but its moderate sales multiple could provide some stability.
Additional Sources for RDC Stock
RDC Stock Overview
| Market Cap in USD | 2,897m |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| GiC Sub-Industry | Drug Retail |
| IPO / Inception |
RDC Stock Ratings
| Growth Rating | 10.4 |
| Fundamental | -10.4 |
| Dividend Rating | 0.0 |
| Rel. Strength | 0.42 |
| Analysts | - |
| Fair Price Momentum | 111.52 EUR |
| Fair Price DCF | 14.28 EUR |
RDC Dividends
No Dividends PaidRDC Growth Ratios
| Growth Correlation 3m | 54% |
| Growth Correlation 12m | 11.5% |
| Growth Correlation 5y | -16.8% |
| CAGR 5y | 8.93% |
| CAGR/Max DD 5y | 0.11 |
| Sharpe Ratio 12m | -0.91 |
| Alpha | -4.32 |
| Beta | 0.457 |
| Volatility | 64.65% |
| Current Volume | 76k |
| Average Volume 20d | 83.3k |
As of May 09, 2025, the stock is trading at EUR 123.50 with a total of 75,961 shares traded.
Over the past week, the price has changed by -6.01%, over one month by -5.80%, over three months by +2.40% and over the past year by -3.67%.
Neither. Based on ValueRay Fundamental Analyses, Redcare Pharmacy is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -10.40 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RDC as of May 2025 is 111.52. This means that RDC is currently overvalued and has a potential downside of -9.7%.
Redcare Pharmacy has no consensus analysts rating.
According to ValueRays Forecast Model, RDC Redcare Pharmacy will be worth about 121.9 in May 2026. The stock is currently trading at 123.50. This means that the stock has a potential downside of -1.3%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 169.4 | 37.1% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 121.9 | -1.3% |